AAAAAA

   
Results: 1-4 |
Results: 4
Schedule-dependent potentiation of chemotherapeutic drugs by the bioreductive compounds NLCQ-1 and tirapazamine against EMT6 tumors in mice
Authors: Papadopoulou, MV Ji, M Bloomer, WD
Citation: Mv. Papadopoulou et al., Schedule-dependent potentiation of chemotherapeutic drugs by the bioreductive compounds NLCQ-1 and tirapazamine against EMT6 tumors in mice, CANC CHEMOT, 48(2), 2001, pp. 160-168
4-[3-(2-nitro-1-imidazolyl)propylamino]-7-chloroquinoline hydrochloride (NLCQ-1), a novel bioreductive agent as radiosensitizer in vitro and in vivo:Comparison with tirapazamine
Authors: Papadopoulou, MV Ji, M Rao, MK Bloomer, WD
Citation: Mv. Papadopoulou et al., 4-[3-(2-nitro-1-imidazolyl)propylamino]-7-chloroquinoline hydrochloride (NLCQ-1), a novel bioreductive agent as radiosensitizer in vitro and in vivo:Comparison with tirapazamine, ONCOL RES, 12(8), 2000, pp. 325-333
4-[3-(2-nitro-1-imidazolyl)propylamino]-7-chloroquinoline hydrochloride (NLCQ-1), a novel bioreductive compound as a hypoxia-selective cytotoxin
Authors: Papadopoulou, MV Ji, M Rao, MK Bloomer, WD
Citation: Mv. Papadopoulou et al., 4-[3-(2-nitro-1-imidazolyl)propylamino]-7-chloroquinoline hydrochloride (NLCQ-1), a novel bioreductive compound as a hypoxia-selective cytotoxin, ONCOL RES, 12(4), 2000, pp. 185-192
Mechanisms involved in the potentiation of melphalan by the bioreductive compound THNLA-1 in vitro
Authors: Papadopoulou, MV Ji, M Khan, SH Bloomer, WD
Citation: Mv. Papadopoulou et al., Mechanisms involved in the potentiation of melphalan by the bioreductive compound THNLA-1 in vitro, ONCOL RES, 11(8), 1999, pp. 345-357
Risultati: 1-4 |